Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis CPHARMACOLOGICAL RESEARCHIF10.52011-01-0143PRE
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver diseaseDIGESTIVE AND LIVER DISEASEIF3.82009-03-0113PREAI
Squamous cell carcinoma antigen (SCCA) expression and CD27+ memory B lymphocytes in patients with chronic hepatitis CJOURNAL OF HEPATOLOGYIF332007-04-011PREAI
Peripheral neurotoxicity of pegylated interferon alpha - A prospective study in patients with HCVNEUROLOGYIF8.52006-09-1229PREAI
Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinomaINTERNATIONAL JOURNAL OF CANCERIF4.72006-06-0159OAAI
Deregulation of Squamous Cell Carcinoma Antigen (SCCA) expression in B lymphocytes in patients with chronic hepatitis CJOURNAL OF CLINICAL VIROLOGYIF3.42006-01-010PREAI
Monitoring SCCA-IgM complex predicts liver disease progression in patients with chronic hepatitis and cirrhosisJOURNAL OF CLINICAL VIROLOGYIF3.42006-01-010PREAI
Profiles of HCV core protein and viremia in chronic hepatitis C: Possible protective role of core antigen in liver damageJOURNAL OF MEDICAL VIROLOGYIF4.62005-01-0114PREAI
Mood, cognition and EEG changes during interferon at (alpha-IFN) treatment for chronic hepatitis CJOURNAL OF AFFECTIVE DISORDERSIF4.92005-01-0151PREAI
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosisGASTROENTEROLOGYIF25.12004-08-01201OA
Kinetic of virological response during PEG-IFNs in chronic hepatitis CJOURNAL OF HEPATOLOGYIF332004-01-012PREAI
Non-invasive diagnosis of liver fibrosis progression by a clinical and US-Doppler predictive model during chronic HCV infectionJOURNAL OF HEPATOLOGYIF332003-04-010PREAI
Epidemiological and clinical profile of HCV chronic carriers in the area of northern ItalyJOURNAL OF HEPATOLOGYIF332003-04-010PREAI
Human leucocyte interferon-alpha in the treatment of chronic hepatitis CDIGESTIVE AND LIVER DISEASEIF3.82001-05-016PREAI
The pattern of response to interferon alpha (α-IFN) predicts sustained response to a 6-month α-IFN and ribavirin retreatment for chronic hepatitis CJOURNAL OF HEPATOLOGYIF332000-07-0125PREAI
Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis CGASTROENTEROLOGYIF25.11997-11-0142OA